Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Yaser Arjeini"'
Publikováno v:
Iranian Journal of Microbiology, Vol 14, Iss 4 (2022)
Background and Objectives: Parvovirus B19 (B19V) is usually transmitted through respiratory tract, but can also be received through blood transfusion. This study evaluated the seroprevalence, DNA existence, and circulating genotypes of B19V in hemoph
Externí odkaz:
https://doaj.org/article/eb0d14286c1a4bc5984e7e56ae7f5dec
Autor:
Mohsen Keshavarz, Ailar Sabbaghi, Seyed Mohammad Miri, Abolhasan Rezaeyan, Yaser Arjeini, Amir Ghaemi
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-17 (2020)
Abstract Compared with conventional cancer treatments, the main advantage of oncolytic virotherapy is its tumor-selective replication followed by the destruction of malignant cells without damaging healthy cells. Accordingly, this kind of biological
Externí odkaz:
https://doaj.org/article/753b7e7bb4ae445d9ff02e077d76f978
Autor:
Mohsen Keshavarz, Farid Solaymani-Mohammadi, Haideh Namdari, Yaser Arjeini, Mohammad Javad Mousavi, Farhad Rezaei
Publikováno v:
Cellular & Molecular Biology Letters, Vol 25, Iss 1, Pp 1-19 (2020)
Abstract Based on available metabolomic studies, influenza infection affects a variety of cellular metabolic pathways to ensure an optimal environment for its replication and production of viral particles. Following infection, glucose uptake and aero
Externí odkaz:
https://doaj.org/article/5f08adfc5fc24ee99ffff48bb901fde9
Autor:
Mohsen Keshavarz, Ailar Sabbaghi, Seyed Mohammad Miri, Abolhasan Rezaeyan, Yaser Arjeini, Amir Ghaemi
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via the original article.
Externí odkaz:
https://doaj.org/article/e130df20d4cd41b69043a258954d9222
Autor:
Mohsen Keshavarz, Somayeh Ghasemi, Yaser Arjeini, Haideh Namdari, Hassan Maleki, Neda Mousavi, Talat Mokhtari‐Azad, Farhad Rezaei
Publikováno v:
Journal of Medical Virology. 95
Autor:
Ailar Sabbaghi, Seyed Mohammad Miri, Abolhasan Rezaeyan, Mohsen Keshavarz, Yaser Arjeini, Amir Ghaemi
Publikováno v:
Cancer Cell International, Vol 20, Iss 1, Pp 1-17 (2020)
Cancer Cell International
Cancer Cell International
Compared with conventional cancer treatments, the main advantage of oncolytic virotherapy is its tumor-selective replication followed by the destruction of malignant cells without damaging healthy cells. Accordingly, this kind of biological therapy c
Autor:
Mohsen Keshavarz, Seyed Mohammad Miri, Emad Behboudi, Yaser Arjeini, Hassan Dianat-Moghadam, Amir Ghaemi
Publikováno v:
International immunopharmacology. 108
Oncolytic viruses (OVs) harness the hallmarks of tumor cells and cancer-related immune responses for the lysis of malignant cells, modulation of the tumor microenvironment, and exertion of vaccine-like activities. However, efficient clinical exploita
Autor:
Mohsen Keshavarz, Seyed Mohammad Miri, Khadijeh Koushki, Amir Ghaemi, Maryam Salemi, Yaser Arjeini
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 144, Iss, Pp 112346-(2021)
Biomedicine & Pharmacotherapy
Biomedicine & Pharmacotherapy
The expansion of myeloid-derived suppressor cells (MDSCs), known as heterogeneous population of immature myeloid cells, is enhanced during several pathological conditions such as inflammatory or viral respiratory infections. It seems that the way MDS
Autor:
Amir Sasan Mozaffari Nejad, Seyed Mohammad Miri, Yaser Arjeini, Amirhossein Darabi, Mohsen Keshavarz, Afagh Yavari, Mehdi Shahgolzari
Publikováno v:
Gene Reports
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) directly interacts with host's epithelial and immune cells, leading to inflammatory response induction, which is considered the hallmark of infection. The host immune system is programmed t
Autor:
Talat Mokhtari-Azad, Vahid Salimi, Hamed Mirzaei, Haideh Namdari, Yaser Arjeini, Mohsen Keshavarz, Ahmadreza Sadeghi, Farhad Rezaei
Publikováno v:
Journal of cellular physiology.
Human influenza A viruses (IAVs) cause global pandemics and epidemics, which remains a nonignorable serious concern for public health worldwide. To combat the surge of viral outbreaks, new treatments are urgently needed. Here, we design a new vaccine